Effects of tamoxifen on ischemia-induced angiogenesis in the mouse lung

Angiogenesis

Volumn 6, Issue 1, 2003, Pages 65-71

  Wagner, Elizabeth M ^a,b   Gallagher, Sandra J ^a   Reddy, Sekhar ^a   Mitzner, Wayne ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Angiogenesis; Lung; Mice; Pulmonary artery obstruction; Tamoxifen; VEGF

Indexed keywords

MESSENGER RNA; PLACEBO; TAMOXIFEN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTERY LIGATION; ARTERY OCCLUSION; ARTICLE; CONTROLLED STUDY; FLUORESCENCE; HEART OUTPUT; INFLAMMATORY CELL; ISCHEMIA; LUNG BLOOD FLOW; MALE; MOUSE; NONHUMAN; PLEURA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; TUMOR GROWTH;

ANIMALS; ESTROGEN ANTAGONISTS; ISCHEMIA; LUNG; MALE; MICE; MICE, INBRED C57BL; MICROSPHERES; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; TAMOXIFEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA;

EID: 0142245806     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025822127847     Document Type: Article

References (28)

1. Lindner DJ, Borden EC. Effects of tamoxifen and interferon-beta or the combination on tumor-induced angiogenesis. Int J Cancer 1997; 71(3): 456-61.
2. McNamara DA, Harmey J, Wang JH et al. Tamoxifen inhibits endothelial cell proliferation and attenuates VEGF-mediated angiogenesis and migration in vivo. Eur J Surg Oncol 2001; 27(8): 714-8.
3. Hyder SM, Chiappetta C, Stancel GM. Triphenylethylene antiestrogens induce uterine vascular endothelial growth factor expression via their partial estrogen agonist activity. Cancer Lett 1997; 120(2): 165-71.
4. Ruohola JK, Valve EM, Karkkainen MJ et al. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol Cell Endocrinol 1999; 149(1-2): 29-40.
5. Hyder SM, Nawaz Z, Chiappetta C, Stancel GM. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res 2000; 60(12): 3183-90.
6. Blackwell KL, Haroon ZA, Shan S et al. Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models. Clin Cancer Res 2000; 6(11): 4359-64.
7. Gagliardi A, Collins DC. Inhibition of angiogenesis by antiestrogens. Cancer Res 1993; 53(3): 533-5.
8. Schraufnagel DE. Monocrotaline-induced angiogenesis. Differences in the bronchial and pulmonary vasculature. Am J Pathol 1990; 137(5): 1083-90.
9. Weibel ER. Early stages in the development of collateral circulation to the lung in the rat. Circ Res 1960; 8: 353-76.
10. Mitzner W, Lee W, Georgakopoulos D, Wagner E. Angiogenesis in the mouse lung. Am J Pathol 2000; 157(1): 93-101.
11. Howe SR, Gottardis MM, Everitt JI, Walker C. Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo. Endocrinology 1995; 136(11): 4996-5003.
12. Yoshidome K, Shibata MA, Couldrey C et al. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: Paradoxical loss of estrogen receptoralpha expression during tumor progression. Cancer Res 2000; 60(24): 6901-10.
13. Evans SM, Koch CJ, Laughlin KM et al. Tamoxifen induces hypoxia in MCF-7 xenografts. Cancer Res 1997; 57(22): 5155-61.
14. Kisanga ER, Gjerde J, Schjott J et al. Tamoxifen administration and metabolism in nude mice and nude rats. J Steroid Biochem Mol Biol 2003; 84(2-3): 361-7.
15. Marti HH, Risau W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci USA 1998; 95(26): 15809-14.
16. Couse JF, Lindzey J, Grandien K et al. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 1997; 138(11): 4613-21.
17. Riley RL, Cournand A. 'Ideal' alveolar air and the analysis of ventilation-perfusion relationships in the lung. J Appl Physiol 1949; 1: 825-847.
18. Charan NB, Carvalho P. Angiogenesis in bronchial circulatory system after unilateral pulmonary artery obstruction. J Appl Physiol 1997; 82(1): 284-91.
19. Michel RP, Hakim TS. Increased resistance in postobstructive pulmonary vasculopathy: Structure-function relationships. J Appl Physiol 1991; 71(2): 601-10.
20. Bausero P, Ben-Mahdi M, Mazucatelli J. Vascular endothelial growth factor is modulated in vascular muscle cells by estradiol, tamoxifen, and hypoxia. Am J Physiol Heart Circ Physiol 2000; 297(5): H2033-42.
21. Adams J, Carder PJ, Downey S et al. Vascular endothelial growth factor (VEGF) in breast cancer: Comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Cancer Res 2000; 60(11): 2898-905.
22. Tsuzuki Y, Fukumura D, Oosthuyse B et al. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha → hypoxia response element → VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res 2000; 60(22): 6248-52.
23. Thompson AM, Kerr DJ, Steel CM. Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer. Br J Cancer 1991; 63(4): 609-14.
24. Srisuma S, Biswal S, Mitzner W et al. Identification of genes promoting angiogenesis in mouse lung by transcriptional profiling. Am J Respir Cell Mol Biol 2003; 29(2): 172-9.
25. Karmpaliotis D, Kosmidou I, Ingenito EP et al. Angiogenic growth factors in the pathophysiology of a murine model of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2002; 283(3): L585-95.
26. Kazi AA, Lee WS, Wagner E, Becker PM. VEGF, fetal liver kinase-1, and permeability increase during unilateral lung ischemia. Am J Physiol Lung Cell Mol Physiol 2000; 279(3): L460-7.
27. Ng YS, Rohan R, Sunday ME et al. Differential expression of VEGF isoforms in mouse during development and in the adult. Dev Dyn 2001; 220(2): 112-21.
28. Pufe T, Wildemann B, Petersen W et al. Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor in the time flow of fracture healing: A study in the rat. Cell Tissue Res 2002; 309(3): 387-92.